v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05213000 |
Full text link
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
mkohut@iastate.edu |
Registration date
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
2022-01-28 |
Recruitment status
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Prevention |
Inclusion criteria
Last imported at : March 3, 2023, noon Source : ClinicalTrials.gov |
inclusion criteria: able to donate a small amount of blood, planning to receive either the initial covid vaccine immunization series or the booster dose (3rd dose) of an mrna-based severe acute respiratory distress syndrome coronavirus 2 vaccine, between 18-70 years of age, regularly participate in some form of exercise, including longer duration exercise sessions can safely perform 90 minutes of light to moderate intensity exercise (walk, walk/jog, or jog) based on american college of sports medicine exercise participation guidelines |
Exclusion criteria
Last imported at : March 3, 2023, noon Source : ClinicalTrials.gov |
currently pregnant presence of any conditions that could significantly impact the ability to exercise safely, or unable to receive the booster vaccine taking medication that significantly impact immune response or the presence of an immune disorder (applies only to initial covid immunization portion of the project) |
Number of arms
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Iowa State University |
Inclusion age min
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
70 |
Countries
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
United States |
Type of patients
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Healthy volunteers |
Severity scale
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : March 3, 2023, noon Source : ClinicalTrials.gov |
200 |
primary outcome
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Change in Gene expression profile;Change in Metabolites;Change in Serum antibody;Change in T cell response |
Notes
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 2143, "treatment_name": "Exercise+mrna vaccine", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |